"The Reflection of Mind" Group exhibition of Paintings by 3 reputed artists from Kolkata At Hirji Jehangir Art Gallery, Kala Ghoda, Mumbai-15-Year-Old Kenyan Girl With Rare Autoimmune Disease Successfully Treated With Cell-based Therapy-Maharashtra Government Inks MoU with IBM Technology for AI Centers-Governor C. P. Radhakrishnan visits Prime Minister Narendra Modi-AMRIT MAHOTSAV OF SHREE MARKET SILK MERCHANTS ASSOCIATION ENDED ON 14TH APRIL, 2025 WITH ALL ITS GRANDEUR-Agra Startup Jatbat Playmax Media Aims to Entertain and Educate with Diverse Book Selection-Indkal Technologies Cements It's Mumbai Presence through Strategic Partnership with Digi1 Electronics-Shree Market Silk Merchants Association (SMSMA) to Celebrate Completion of Amrut Mahotsav on 14th April-SUPREME COURT TAKES COGNIZANCE OF CHILD SAFETY CONCERNS IN DIGITAL SPACE-TechnoServe and The Solvent Extractors’ Association of India Sign Landmark MoU to Advance Edible Oil Fortification

#Dr. Reddy’s Laboratories Ltd.

BUSINESS, Corporate, HOME, Hospital, Health & Pharma, INDUSTRY, NATION, STATE December 31, 2019

Dr. Reddy’s Laboratories announces the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market

HYDERABAD, INDIA, PRINCETON, NJ, USA. DECEMBER 31, 2019 (GPN)— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sodium Nitroprusside…